5AM Partners VII, LLC

10% OwnerSkye Bioscience, Inc. (SKYE) · full profile →Form 4 · filed Aug 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$140K
Net Open-Market Flow
-$140K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2026Sell(S)6K$0.32$2K7.9M
Aug 20, 2026Sell(S)1K$0.32$3711.4M
Aug 20, 2026Sell(S)46$0.32$1555K
Aug 19, 2026Sell(S)409$0.35$14355K
Aug 19, 2026Sell(S)10K$0.35$4K1.4M
Aug 19, 2026Sell(S)57K$0.35$20K7.9M
Aug 18, 2026Sell(S)45K$0.38$17K1.4M
Aug 18, 2026Sell(S)253K$0.38$96K7.9M
Aug 18, 2026Sell(S)2K$0.38$69556K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000959) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about SKYE insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001231919-26-000959"
Ask your agent
Use Arkolith to summarize insider buying and selling at Skye Bioscience, Inc.
over the last 90 days and cite the filings.